Raymond James Financial Services Advisors, Inc. Veracyte, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 83,004 shares of VCYT stock, worth $2.67 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,004Holding current value
$2.67 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
337Shares Held
76.8MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$264 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$250 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$212 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$135 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$99 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.3B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...